Moreover, plasma HGF strongly associated with Model for End-stage Liver Disease (MELD) score, a validated measure of liver disease severity, in HCC patients undergoing liver transplantation (Spearman rho = 0.54, p < 0.0001). This evidence concerns the gene HGF and hepatocellular carcinoma.